Science for a better life

Latest News

For media enquiries please contact one of the following people:

Pharmaceuticals and Consumer Health: Michelle D'Heureux
Phone: +61 428 502 682

Crop Science and Animal Health: Lachlan Bird
Phone: +61 3 9248 6851

Bayer New Zealand: William Malpass
Phone: +64 9 441 8591

News

Wednesday - September 05, 2018

Second quarter of 2018
Bayer completes biggest acquisition in its history More

Tuesday - August 07, 2018

Bayer’s ongoing partnership provides greater access to medical services in the bush
We are committed to addressing the burden of cardiovascular disease through our support of the Heart of Australia mobile cardiology clinic More

Friday - August 03, 2018

New Pest Partner app launched for pest controllers, distributors and homeowners
The app is fully customizable by country and for intended users, e.g. professional pest controllers; distributors or home-owners More

Tuesday - July 24, 2018

Health Yourself – why you should care about self-care
We’ve seen significant advances in modern medicine, however, consistent with our growing and ageing population and our modern lifestyles, chronic disease is on the rise. Find out what you can do to look after yourself. More

Wednesday - July 18, 2018

Cattle producers take pain relief by the horns
Tri-Solfen from Bayer now registered for use for dehorning and disbudding in calves More

Friday - May 25, 2018

Bayer is making good progress strategically
Acquisition of Monsanto expected to be closed in the near future / 2017 sales and earnings at the prior-year level / Dividend to be raised for the eighth time in succession – to 2.80 euros per share / Start to fiscal 2018 overshadowed by currency effects More

Thursday - May 03, 2018

Bayer Q1 2018: Operational business held back by currency effects – Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx & portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year due to currency effects / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and additional regulators conditionally approve Monsanto acquisition / Currency adjusted Group outlook for 2018 confirmed More

Wednesday - April 04, 2018

Combining tradition with modernity:
Bayer hones its brand profile More

Wednesday - March 21, 2018

European Commission conditionally approves Bayerâ€™s proposed acquisition of Monsanto
Closing of transaction planned for the second quarter of 2018 More

Wednesday - February 28, 2018

Transfers of Value to Healthcare Professionals
Bayer is a strong advocate of the pharmaceutical industryâ€™s ongoing efforts to increase transparency around its business. More

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33